Skip to main content

Table 2 Patient characteristics

From: Clinical significance of Akt and HER2/neu overexpression in African-American and Latina women with breast cancer

  Number Percentage P value
Total 141 100  
Ethnicity    
   African-American 72 51.1  
   Latina 69 48.9 0.801
Age at diagnosis    
   <50 years 73 51.8  
   ≥ 50 years 68 48.2 0.674
Tumor size    
   <5 cm 90 63.8  
   ≥ 5 cm 51 36.2 0.001
Lymph node status    
   Positive 89 63.1  
   Negative 52 36.9 0.004
AJCC stage    
   0–II 88 62.4  
   III–IV 53 37.6 0.004
Histological grade    
   Well to moderately differentiated 43 30.5  
   Poorly differentiated 98 69.5 0.001
ER/PR status    
   ER/PR+ 81 57.4  
   ER/PR- 60 42.6 0.086
HER2/neu status    
   Positive 46 32.6  
   Negative 95 67.4 0.001
pAkt level    
   High 71 50.4  
   Low 70 49.6 0.933
  1. AJCC, American Joint Committee on Cancer; ER/PR, estrogen receptor/progesterone receptor; HER2/neu negative, HER2/neu 2+ and 1+ and negative; HER2/neu positive, HER2/neu 3+ determined by immunohistochemistry; pAkt level high, pAkt index of greater than 36 (median level); pAkt level low, pAkt index of less than or equal to 36.